SBIR/STTR Research Award

Novel Materials for Viral Purification

Award identifier 78a3a62d2fcfe19a549ed1370d396dc28a871debdc15ef84f7c5c2aa180d884aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,166

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ABREOS BIOSCIENCES, INC.
Proposal award date
2017-09-01
Contract end date
2019-04-30
UEI
KM24BL6J7XG3
Solicitation number
PA16-302
Topic code
102

Research abstract

Abstract Viruses have significant commercial application as vectors for gene and cell therapy as well as vaccines for cancer treatment and infectious diseases The purification of commercial viruses is a major area of bioprocess development Current methods are mostly based on filtration and chromatography both of which scale poorly and require clean feed streams to perform well Viral particles are difficult to recover from culture supernatants or cell lysates because they are similar in size to cell debris A large amount of expensive high quality nuclease Benzonase is typically needed to reduce the viscosity of the lysate sufficiently for efficient membrane and column operations Affinity based vector purification has been developed for only one type of vector some strains of adeno associated virus and is also very expensive In summary virus purification is challenging and significant amounts of valuable product are lost in inefficient filters We have developed a novel DNA based avidity reagent termed DeNAno that can provide a significant advance in the development and manufacturing of commercial viruses with applicability to a variety of viral vectors DeNAno uses massive avidity rather than affinity to capture biologic targets such as viruses DeNAno particles are composed of a single stranded DNA concatemer which contains several hundred copies of a template oligonucleotide The goal of this project is to develop DeNAno particles that bind to a target virus and then use the DeNAno as a capture reagent for virus purification DeNAno libraries are produced by rolling circle replication of a circular oligonucleotide template containing a random sequence and specific viral binders are recovered by a biopanning process DeNAno particles can be released from their targets by disrupting their secondary structure through divalent cation removal they can also be labeled with nano particulate magnetite or coated onto micron sized magnetite to allow their use as magnetic capture reagents We have already performed a selection on adenovirus coated beads and obtained a pool of DeNAno particles that bind the target virus The specific aims of this project are to characterize DeNAno particles that bind to the model virus adenovirus and demonstrate their use as a purification tool by attaching them to magnetite so that they can be used in magnetic capture The virus will be released following capture by divalent cation removal and the magnetic DeNAno cleared from the viral preparation again by magnet We will assess the capture efficiency virus yield and infectivity residual DeNAno contamination and the presence of host cell proteins in the final preparation If successful this project will demonstrate the potential of the DeNAno technology to streamline virus production and pave the way for additional DeNAno based applications targeting other commercially important viruses One application of viruses is as a treatment for different diseases including cancer but these viruses are difficult and expensive to manufacture at sufficient purity This project will develop a new technique that replaces several cumbersome virus production steps with a simpler and cheaper method of purifying viruses from their cellular source material

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

11 SBIR/STTR records share this UEI (2014–2019). Reported award amounts total $5,088,511. Reported amounts are not federal obligations.

Phases: Phase I, Phase II – Direct to Phase II, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.